On Monday, Quest Diagnostics, Inc. (NYSE: DGX) was 1.28% up from the session before settling in for the closing price of $128.44. A 52-week range for DGX has been $119.59 – $148.62.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 4.86%. When this article was written, the company’s average yearly earnings per share was at 0.44%. With a float of $109.71 million, this company’s outstanding shares have now reached $111.00 million.
The extent of productivity of a business whose workforce counts for 48000 workers is very important to gauge.
Quest Diagnostics, Inc. (DGX) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Quest Diagnostics, Inc. stocks. The insider ownership of Quest Diagnostics, Inc. is 0.90%, while institutional ownership is 91.01%. The most recent insider transaction that took place on Feb 29 ’24, was worth 706,313. In this transaction SVP & General Counsel of this company sold 5,611 shares at a rate of $125.88, taking the stock ownership to the 38,478 shares. Before that another transaction happened on Feb 29 ’24, when Company’s EVP, Regional Businesses sold 1,187 for $125.88, making the entire transaction worth $149,420. This insider now owns 68,412 shares in total.
Quest Diagnostics, Inc. (DGX) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 12/31/2023, it has been observed that the corporation posted $2.15 earnings per share (EPS) during the time that was better than consensus figure (set at $2.11) by $0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 0.44% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.21% during the next five years compared to 7.36% growth over the previous five years of trading.
Quest Diagnostics, Inc. (NYSE: DGX) Trading Performance Indicators
You can see what Quest Diagnostics, Inc. (DGX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.20. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.56. Likewise, its price to free cash flow for the trailing twelve months is 16.67.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 7.49, a number that is poised to hit 1.86 in the next quarter and is forecasted to reach 9.41 in one year’s time.
Technical Analysis of Quest Diagnostics, Inc. (DGX)
The latest stats from [Quest Diagnostics, Inc., DGX] show that its last 5-days average volume of 1.14 million was superior to 1.04 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 36.02%. Additionally, its Average True Range was 2.31.
During the past 100 days, Quest Diagnostics, Inc.’s (DGX) raw stochastic average was set at 34.24%, which indicates a significant decrease from 54.11% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 16.98% in the past 14 days, which was lower than the 18.39% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $128.31, while its 200-day Moving Average is $131.28. Now, the first resistance to watch is $131.41. This is followed by the second major resistance level at $132.72. The third major resistance level sits at $134.23. If the price goes on to break the first support level at $128.58, it is likely to go to the next support level at $127.07. Assuming the price breaks the second support level, the third support level stands at $125.75.
Quest Diagnostics, Inc. (NYSE: DGX) Key Stats
There are 111,056K outstanding shares of the company, which has a market capitalization of 14.40 billion. As of now, sales total 9,252 M while income totals 854,000 K. Its latest quarter income was 2,288 M while its last quarter net income were 192,000 K.
